IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a lethal condition, and therefore novel approaches are needed. Monocyte-derived dendritic cells (mDCs) pulsed with tumor antigens, as professional antigen-presenting cells, are a promising strategy for immunotherapy of invasive brain tumors. MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Madrid, Andres Morales La, Mora, Jaume, Cruz, Ofelia, Lopez, Vicente Santa-Maria, Perez-Jaume, Sara, Guillen, Antonio, Paco, Sonia, Carcaboso, Angel M, Puerta, Patricia, Salvador, Noelia, Juan, Manuel, Benitez-Ribas, Daniel, Cabezon, Raquel, Flórez-Grau, Georgina, Molero, Mari Carmen
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715823/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.378
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados